News

Hims & Hers Health, Inc. (HIMS) Alleged“Deceptive” Marketing Of Wegovy® Triggers Securities Class Actions HIMS Investors With Losses Encouraged To Contact Hagens Berman
National shareholders rights firm Hagens Berman continues to investigate the legal claims and urges Hims & Hers investors who suffered substantial losses to submit your losses now . The firm also ...
ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Hims & Hers Health, Inc. Investors To Secure Counsel Before Important Deadline In Securities Class Action HIMS
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive ...
Drugmaker telehealth deals risk unnecessary prescribing, Senate probe finds
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to pharmaceutical companies Pfizer and Eli Lilly.
Zacks Investment Research on MSN8h
Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally?
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock lately despite its ...
USA Herald12h
Hims & Hers Executives Face Lawsuit Over Knockoff Wegovy Sales
Executives and directors of Hims & Hers Health Inc., a leading telehealth company, are facing a shareholder derivative ...